An accomplished scientist, venture capitalist and biotech entrepreneur with a career centered on discovery, development, and innovation in life sciences. Leadership at Genentech was as a research director responsible for generating drug candidates. Working at the cutting edge of technology, biology and medicine led to a career in venture capital. Established a successful track record as a VC in building, investing, and generating returns in therapeutic, diagnostic, and research tools companies. Entrepreneurial and corporate leadership includes co-founding two biotechnology companies, Aeglea BioTherapeutics (NASDAQ: AGLE) and Delta TpX, Inc., and at Shattuck Labs Inc., (NASDAQ: STTK) as an investor, advisor, and Vice Chair of the Board. An executive, scientific leader and company builder prepared to bring a unique skill set to companies striving to develop new technology, create value and address significant medical needs.